We have over 15 years of experience

logo
  • +(962) 6 5512561/2 , +(971) 569498820

  • contact@sipsmena.com

  • 8:30am - 5:30pm

  • Sunday to Thursday




Globalization of Arabian Pharma
 
Globalization of Arabian pharmaceutical industry to meet the challenges of the agreement on Trade-related Aspects of Intellectual Property Rights” (TRIPS)
(21st -23rd  Feb 2010 – Sharm El Sheikh / Egypt).
 
Seminar themes
 
1. Present training & development systems in the field of regulatory affairs and focus on “Common Technical Document CTD”
2. Emphasize the role of human resources for  (GMP), to enhance the globalization of Arabian pharmaceutical industry.
3. Monitor & analyzes current reality for Pharmaceutical industry in Arab countries.
4. Identification of QC standards &QA standards to produce safe & effective  pharmaceutical as conformity with standards  specifications of EP, USA & Japanese quality standards 
5. Emphasize the role of universities & scientific research centers in the innovation of new pharmaceuticals & legalizations for Innovators &consent protection. 
6. The role of strategic merge & take over between Arabian –Arabian pharmaceutical companies &Arabian multinational pharmaceutical companies, & importance of expansions & Technology transfer to give a competitive edge in the global market.
 
 
Speakers: 
 
Dr. Awad Taj Al-Din
Dr. Tawfeeq Khoga
Dr. Majdi Hasan
Dr. Saleh Bawazir
Dr. Mohammed Al-Haidari
Dr. Osama Al-Sa’adi
Dr. Mohammed Saleem 
 
Summary 
 
The forum aims to:
1. Present the training & development systems in the field of regulatory affairs and focus on “Common Technical Document CTD”. 
2. Emphasize the role of human resources in developing and supporting the strategic plans for “Good Manufacturing Process (GMP)”, to enhance the globalization of Arabian pharmaceutical industry.
3. Monitor & analyzes the current reality for the pharmaceutical industry in the Arab countries, the challenges meeting this industry, and the role of modernization programs in some Arab countries to meet these challenges towards global Market.
4. Identification of quality control standards and quality assurance standards to produce a safe & effective  pharmaceutical as conformity with standards  specifications of European, USA and Japanese quality standards 
- European Medicines Agency (EMEA)
- Food and Drugs Administration (FDA-USA)
- (Japan) Ministry of Health, Labor & Welfare.( MHLW)
5. Discuss the global  quality standards applications  “Quality Control, Quality Assurance, Inspection &Audit”  
6. Emphasize the role of universities & scientific research centers in the innovation the new pharmaceuticals and the legalizations for Innovators and content protection.  
7. Clarify the importance of vaccine industries development as a strategic industry of the Arab Countries. 
8. The importance of Good Distribution Process (DSP).
9. The role of strategic merge and take over between Arabian –Arabian pharmaceutical companies and Arabian multinational pharmaceutical companies, and the importance of expansions & Technology transfer to give a competitive edge in the global market.  
10. Clarify the role of Arab institutions to enhance good Arab pharmaceutical industry for Arab pharmaceutical industry in the framework of the globalization challenges economic. 
11. The strict legal clarification provisions of the TRIPS agreement on the protection of the pharmaceutical industry patents rights and the exceptions contained on it.
12. Clarify the provisions affect agreement on the Arab world pharmaceutical industry, cause the competition posed by the multinational companies which seeks to monopolize the pharmaceutical  industry especially for new drugs dealing with emerging epidemics or the medicines which depend on the genetic engineering as the national companies cannot produce any form it as they have not a patents invented .
13. Explain the changes proposed to the agreement on the protection of intellectual property rights during Doha round negotiation.
14. The successful presentation of the experience of some Arab pharmaceutical companies.
15. Reach the recommendation on the development mechanism of the Arab pharmaceutical trade, and the strengthening the positions of the Arab pharmaceutical companies as well as creating the common negotiation position in Doha round to maximize in using the agreement on the protection of intellectual property right. and to leverage it to the concerned directions as they work on their implementation ( Brochure attached)
 
- The forum hosting the officials’ health ministry, pharmaceutical Affaire's administration leaders and the Arab countries pharmaceutical registration directors, and there will be an opportunity on the forum sidelines to communicate between the Arab drugs companies and the pharmaceutical registration aiming to develop the Arab intermediate pharmaceutical trade.
That will be establishment an exhibition on the forum sidelines for the products and brochures institutions and the sponsor's companies.